The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score
Open accessAbstract
Background Current guidelines advocate a step-wise approach to disease-modifying treatment of primary biliary cholangitis (PBC): all patients begin treatment with ursodeoxycholic acid (UDCA) monotherapy – and those with inadequate biochemical response to UDCA are subsequently considered for second-line therapies, the conventional period to demonstrate inadequate UDCA response being 12 months. A potential limitation with this approach, however, is that patients at highest risk end up waiting longest for effective treatment. In this study, we sought to determine whether UDCA response can be accurately predicted using pre-treatment clinical parameters, so that alternative approaches to treatment stratification might be explored. Methods We undertook logistic regression analysis of pre-treatment variables in 2,703 UDCA-treated patients to derive the best-fitting model of UDCA response, defined as ALPT12 < 1.67×ULN. We validated the model in an external PBC cohort from Italy (n=460). Finally, we explored the biological plausibility of the model by looking for correlation between model predictions and key histological features on PBC liver biopsies (n = 20), such as biliary injury and fibrosis. Findings The following pre-treatment parameters were associated with lower probability of UDCA response: higher ALP (p<0.0001), higher bilirubin (p=0.0003), lower transaminases (TA, p=0.0012), younger age (p<0.0001), longer interval from diagnosis to the start of UDCA (treatment time lag, p<0.0001), and worsening of ALP from diagnosis (ΔALP, p<0.0001). Based on these variables, we derived a predictive score of UDCA response: UDCAresponsescore(URS)=0.77+0.60×(TBdiag)−1−2.73×ln(ALPdiag)+0.35×ln(TAdiag)+0.03×age−0.15×(treatmenttimelag)−0.56×ΔALP In external validation, the AUROC was 0.83 (0.79-0.87). In PBC liver biopsies, the URS was associated with ductular reaction (DR) and intermediate hepatocytes (IH). Interpretation We have derived and externally validated a model based on pre-treatment variables that accurately predicts UDCA response. Association with DR and IH provides face validity. Thus, this model provides a basis to explore alternative approaches to treatment stratification in PBC. Fundings Medical Research Council (MR/L001489/1); University of Milan-Bicocca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At a population level, UDCA improves serum liver biochemical markers, delays liver transplantation and increases life expectancy.21013”
From Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid (2026) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“UK-PBC studies have demonstrated that therapy delay in PBC leads to a significantly reduced likelihood that the therapy will work when eventually used.10”
From Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid (2026) · cites this paper as [10]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“studies from UK-PBC have clearly shown that UDCA treatment failure can be accurately predicted by pretreatment clinical parameters including the patient’s age and serum biochemistry.10”
The cited source says what the claim attributes to it.
In the citing paper
“It is clear, however, that the likelihood of response to UDCA can be predicted with accuracy at the outset of disease, and algorithms developed to allow prediction in practice.10”
The cited source says what the claim attributes to it.
In the citing paper
“A predictive model of response to ursodeoxycholic acid treatment was developed based on pretreatment clinical factors and biochemistries, 121 and was validated in other cohorts.122,123”
From Primary biliary cholangitis. (2024) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histological grading and staging of chronic hepatitis.
Ishak, K., Baptista, A., Bianchi, L., Callea, F., Groote, J. D., Gudat, F., Denk, H., Desmet, V., Korb, G., Macsween, R. N., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,290
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Self-citationA Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary Cirrhosis
Poupon, R. E., Balkau, B., Eschwège, E., Poupon, R., & the UDCA–PBC Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199105303242204 · Cited by 755
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
Ludwig, J., Dickson, E. R., & McDonald, G. S. A. (1978) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00432479 · Cited by 753
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
McKinney, E. F., Lee, J. C., Jayne, D. R. W., Lyons, P. A., & Smith, K. G. C. (2015) · Nature · doi:10.1038/nature14468 · Cited by 685
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
Corpechot, C., Chazouillères, O., Rousseau, A., Le Gruyer, A., Habersetzer, F., Mathurin, P., Goria, O., Potier, P., Minello, A., Silvain, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714519 · Cited by 642
Lammers, W. J., van Buuren, H. R., Hirschfield, G. M., Janssen, H. L. A., Invernizzi, P., Mason, A. L., Ponsioen, C. Y., Floreani, A., Corpechot, C., Mayo, M. J., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.029 · Cited by 498
Self-citationUrsodiol for the Long-Term Treatment of Primary Biliary Cirrhosis
Poupon, R. E., Poupon, R., & Balkau, B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405123301903 · Cited by 497
Hepatic progenitor cells of biliary origin with liver repopulation capacity
Lu, W.-Y., Bird, T. G., Boulter, L., Tsuchiya, A., Cole, A. M., Hay, T., Guest, R. V., Wojtacha, D., Man, T. Y., Mackinnon, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3203 · Cited by 479
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis
Liu, X., Invernizzi, P., Lu, Y., Kosoy, R., Lu, Y., Bianchi, I., Podda, M., Xu, C., Xie, G., Macciardi, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.627 · Cited by 398
Self-citation
Cited by
Sorted by citations
Primary biliary cholangitis: pathogenesis and therapeutic opportunities
Gulamhusein, A. F., & Hirschfield, G. M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0226-7 · Cited by 308
Self-citationLleo, A., Wang, G.-Q., Gershwin, M. E., & Hirschfield, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31607-x · Cited by 253
Self-citationTanaka, A., Ma, X., Takahashi, A., & Vierling, J. M. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01303-5 · Cited by 177
Current understanding of primary biliary cholangitis
Tanaka, A. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0028 · Cited by 169
Primary biliary cholangitis: Epidemiology, prognosis, and treatment
Trivella, J., John, B. V., & Levy, C. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000179 · Cited by 159
Tanaka, A., Hirohara, J., Nakano, T., Matsumoto, K., Chazouillères, O., Takikawa, H., Hansen, B. E., Carrat, F., & Corpechot, C. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.04.010 · Cited by 148
You, H., Ma, X., Efe, C., Wang, G., Jeong, S.-H., Abe, K., Duan, W., Chen, S., Kong, Y., Zhang, D., et al. (2022) · Hepatology International · doi:10.1007/s12072-021-10276-6 · Cited by 133
Current and potential treatments for primary biliary cholangitis
Shah, R. A., & Kowdley, K. V. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30343-7 · Cited by 117
The challenges of primary biliary cholangitis: What is new and what needs to be done
Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., Vergani, D., Vierling, J. M., Adams, D., Alpini, G., Banales, J. M., Beuers, U., Björnsson, E., Bowlus, C., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102328 · Cited by 114
Self-citationReal-world experience with obeticholic acid in patients with primary biliary cholangitis
D’Amato, D., De Vincentis, A., Malinverno, F., Viganò, M., Alvaro, D., Pompili, M., Picciotto, A., Palitti, V. P., Russello, M., Storato, S., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100248 · Cited by 85
Self-citationDrug Therapies for Chronic Cholestatic Liver Diseases
Wagner, M., & Fickert, P. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021059 · Cited by 75
Cristoferi, L., Calvaruso, V., Overi, D., Viganò, M., Rigamonti, C., Degasperi, E., Cardinale, V., Labanca, S., Zucchini, N., Fichera, A., et al. (2021) · Hepatology · doi:10.1002/hep.31810 · Cited by 69
Self-citationGerussi, A., Bernasconi, D. P., O’Donnell, S. E., Lammers, W. J., van Buuren, H., Hirschfield, G. M., Janssen, H. L. A., Corpechot, C., Reig, A., Parés, A. R., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.08.006 · Cited by 62
Self-citationMarschall, H., Henriksson, I., Lindberg, S., Söderdahl, F., Thuresson, M., Wåhlin, S., & Ludvigsson, J. F. (2019) · Scientific Reports · doi:10.1038/s41598-019-47890-2 · Cited by 61
The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis
Barron‐Millar, B., Ogle, L., Mells, G., Flack, S., Badrock, J., Sandford, R., Kirby, J., Palmer, J., Jopson, L., Brain, J., et al. (2021) · Hepatology · doi:10.1002/hep.32011 · Cited by 45
Self-citationThe pathogenesis, models and therapeutic advances of primary biliary cholangitis
Li, H., Guan, Y., Han, C., Zhang, Y., Liu, Q., Wei, W., & Ma, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111754 · Cited by 59
Park, J. W., Kim, J. H., Kim, S. E., Jung, J. H., Jang, M. K., Park, S. H., Lee, M. S., Kim, H. S., Suk, K. T., & Kim, D. J. (2022) · Biomedicines · doi:10.3390/biomedicines10061288 · Cited by 60
P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases
Zhang, J., Lyu, Z., Li, B., You, Z., Cui, N., Li, Y., Li, Y., Huang, B., Chen, R., Chen, Y., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000317 · Cited by 57
Bowlus, C. L., Yang, G., Liu, C. H., Johnson, C. R., Dhaliwal, S. S., Frank, D., Levy, C., Peters, M. G., Vierling, J. M., & Gershwin, M. E. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.04.005 · Cited by 56
Liu, Y., Guo, G., Zheng, L., Sun, R., Wang, X., Deng, J., Jia, G., Yang, C., Cui, L., Guo, C., et al. (2023) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002238 · Cited by 55
Efficacy and safety of anti-hepatic fibrosis drugs
Damiris, K., Tafesh, Z., & Pyrsopoulos, N. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i41.6304 · Cited by 52
Nevens, F., Trauner, M., & Manns, M. P. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.10.007 · Cited by 51
Contribution of Resident Stem Cells to Liver and Biliary Tree Regeneration in Human Diseases
Overi, D., Carpino, G., Cardinale, V., Franchitto, A., Safarikia, S., Onori, P., Alvaro, D., & Gaudio, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102917 · Cited by 52
Self-citationPrimary biliary cholangitis: pathogenic mechanisms
Prìeto, J., Bañales, J. M., & Medina, J. F. (2020) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000703 · Cited by 48
Efe, C., Taşçılar, K., Henriksson, I., Lytvyak, E., Alalkim, F., Trivedi, H. D., Eren, F., Eliasson, J., Beretta‐Piccoli, B. T., Fischer, J., et al. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000290 · Cited by 48
Self-citationBiological synthesis of ursodeoxycholic acid
Song, P., Zhang, X., Feng, W., Xu, W., Wu, C., Xie, S., Yu, S., & Fu, R. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1140662 · Cited by 47
John, B. V., Khakoo, N. S., Schwartz, K. B., Aitchenson, G., Levy, C., Dahman, B. A., Deng, Y., Goldberg, D. S., Martin, P. B., Kaplan, D. E., et al. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001280 · Cited by 47
UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis
Abbas, N., Culver, E. L., Thorburn, D., Halliday, N., Crothers, H., Dyson, J. K., Phaw, N. A., Aspinall, R., Khakoo, S. I., Kallis, Y. N., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.07.038 · Cited by 42
Self-citationMurillo Perez, C. F., Ioannou, S., Hassanally, I., Trivedi, P. J., Corpechot, C., van der Meer, A. J., Lammers, W. J., Battezzati, P. M., Lindor, K. D., Nevens, F., et al. (2023) · Liver International · doi:10.1111/liv.15592 · Cited by 39
Self-citationTerziroli Beretta-Piccoli, B., Stirnimann, G., Mertens, J., Semela, D., Zen, Y., Mazzucchelli, L., Voreck, A., Kolbus, N., Merlo, E., Di Bartolomeo, C., et al. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102578 · Cited by 39
Montaño‐Loza, A. J., & Corpechot, C. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.06.062 · Cited by 41
Review article: pathophysiology and management of primary biliary cholangitis
Leung, K. K., Deeb, M., & Hirschfield, G. M. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16023 · Cited by 39
Self-citationPrimary biliary cholangitis: Personalizing second-line therapies
Levy, C., & Bowlus, C. L. (2024) · Hepatology · doi:10.1097/hep.0000000000001166 · Cited by 39
Gazda, J., Dražilová, S., Gazda, M., Janíčko, M., Koky, T., Macej, M., Carbone, M., & Jarčuška, P. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2022.12.010 · Cited by 36
Self-citationArtificial intelligence for precision medicine in autoimmune liver disease
Gerussi, A., Scaravaglio, M., Cristoferi, L., Verda, D., Milani, C., Bernardi, E. D., Ippolito, D., Asselta, R., Invernizzi, P., Kather, J. N., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.966329 · Cited by 37
Self-citationAbbas, N., Smith, R., Flack, S., Bains, V., Aspinall, R. J., Jones, R. L., Burke, L., Thorburn, D., Heneghan, M., Yeoman, A., et al. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2023.100931 · Cited by 31
Self-citationNew Therapies on the Horizon for Primary Biliary Cholangitis
Tanaka, A. (2023) · Drugs · doi:10.1007/s40265-023-01979-1 · Cited by 33
Vincentis, A. D., D’Amato, D., Cristoferi, L., Gerussi, A., Malinverno, F., Lleò, A., Colapietro, F., Marra, F., Galli, A., Fiorini, C., et al. (2022) · Liver International · doi:10.1111/liv.15386 · Cited by 30
Self-citationHu, Y., Bao, X., Zhang, Z., Chen, L., Liang, Y., Qu, Y., Zhou, Q. Y., Zhou, X., Fang, J., Xiao, Z., et al. (2024) · Theranostics · doi:10.7150/thno.91572 · Cited by 31
Bossen, L., Rebora, P., Bernuzzi, F., Jepsen, P., Gerussi, A., Andreoné, P., Galli, A., Beretta‐Piccoli, B. T., Alvaro, D., Labbadia, G., et al. (2020) · Liver International · doi:10.1111/liv.14466 · Cited by 29
Self-citationPrognostic models in primary biliary cholangitis
Cristoferi, L., Nardi, A., Ronca, V., Invernizzi, P., Mells, G. F., & Carbone, M. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.024 · Cited by 28
Self-citationThe Management of Cholestatic Liver Diseases: Current Therapies and Emerging New Possibilities
Mazzetti, M., Marconi, G., Mancinelli, M., Benedetti, A., Marzioni, M., & Maroni, L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081763 · Cited by 30
Self-citationOveri, D., Carpino, G., Cristoferi, L., Onori, P., Kennedy, L. L., Francis, H., Zucchini, N., Rigamonti, C., Viganò, M., Floreani, A., et al. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100556 · Cited by 28
Self-citationQuality of life in patients with primary biliary cholangitis: A cross-geographical comparison
Montali, L., Gragnano, A., Miglioretti, M., Frigerio, A., Vecchio, L., Gerussi, A., Cristoferi, L., Ronca, V., D’Amato, D., O’Donnell, S. E., et al. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100081 · Cited by 26
Self-citationCell transplantation-based regenerative medicine in liver diseases
Cardinale, V., Lanthier, N., Baptista, P. M., Carpino, G., Carnevale, G., Orlando, G., Angelico, R., Manzia, T. M., Schuppan, D., Pinzani, M., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.06.005 · Cited by 27
Self-citationAlvaro, D., Carpino, G., Craxì, A., Floreani, A., Moschetta, A., & Invernizzi, P. (2020) · Liver International · doi:10.1111/liv.14627 · Cited by 23
Self-citationMachine learning in primary biliary cholangitis: A novel approach for risk stratification
Gerussi, A., Verda, D., Bernasconi, D. P., Carbone, M., Komori, A., Abe, M., Inao, M., Namisaki, T., Mochida, S., Yoshiji, H., et al. (2021) · Liver International · doi:10.1111/liv.15141 · Cited by 23
Self-citationYagi, M., Matsumoto, K., Komori, A., Abe, M., Hashimoto, N., Inao, M., Namisaki, T., Kawata, K., Ninomiya, M., Fujii, H., et al. (2020) · Liver International · doi:10.1111/liv.14534 · Cited by 20
Gut microbiome pattern impacts treatment response in primary biliary cholangitis
Liu, Q., Huang, B., Zhou, Y., Wei, Y., Li, Y., Li, B., Li, Y., Zhang, J., Qian, Q., Chen, R., et al. (2024) · Med · doi:10.1016/j.medj.2024.08.003 · Cited by 20
Gerussi, A., D’Amato, D., Cristoferi, L., O’Donnell, S. E., Carbone, M., & Invernizzi, P. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2019.09.009 · Cited by 20
Self-citationEmerging novel treatments for autoimmune liver diseases
Tanaka, A. (2019) · Hepatology Research · doi:10.1111/hepr.13347 · Cited by 19
Yu, K., Li, P., Xu, T., Xu, J., Wang, K., Chai, J., Zhao, D., Liu, Y., Wang, Y., Ma, J., et al. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.153291 · Cited by 17
Primary biliary cholangitis and the narrowing gap towards optimal disease control
Cançado, G. G. L., Lleò, A., Levy, C., Trauner, M., & Hirschfield, G. M. (2025) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(25)00025-1 · Cited by 20
Self-citationDistinct EpCAM-Positive Stem Cell Niches Are Engaged in Chronic and Neoplastic Liver Diseases
Safarikia, S., Carpino, G., Overi, D., Cardinale, V., Venere, R., Franchitto, A., Onori, P., Alvaro, D., & Gaudio, E. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00479 · Cited by 16
Self-citationKawata, K., Joshita, S., Shimoda, S., Yamashita, Y., Yamashita, M., Kitsugi, K., Takatori, S., Ohta, K., Ito, J., Shimoyama, S., et al. (2020) · Hepatology Research · doi:10.1111/hepr.13584 · Cited by 16
Autoantibodies in Primary Biliary Cholangitis
Leung, K. K., & Hirschfield, G. M. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.06.004 · Cited by 15
Self-citationReasons why women are more likely to develop primary biliary cholangitis
Ma, D., Ma, J., Zhao, C., & Tai, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25634 · Cited by 18
Carbone, M., Gerussi, A., Cardinale, V., Cazzagon, N., Cossiga, V., Lleò, A., Marrone, G., Marzioni, M., Moschetta, A., Muratori, L., et al. (2024) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.05.002 · Cited by 18
Self-citationKimura, N., Takamura, M., Takeda, N., Watanabe, Y., Arao, Y., Takatsuna, M., Takeuchi, S., Abé, H., Setsu, T., Kamimura, H., et al. (2021) · Hepatology International · doi:10.1007/s12072-021-10163-0 · Cited by 14
Current and promising therapy for primary biliary cholangitis
Gossard, A. A., & Lindor, K. D. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1601701 · Cited by 15
Liang, Y., Li, J., Zhang, Z., Jiang, T., & Yang, Z. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102321 · Cited by 14
Vincentis, A. D., Ampuero, J., Terracciani, F., D’Amato, D., Gerussi, A., Cristoferi, L., Cazzagon, N., Bonaiuto, E., Floreani, A., Calvaruso, V., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.05.008 · Cited by 12
Self-citationWiegand, J., Franke, A., Müller, T., Stein, K., Bantel, H., Günther, R., Denk, G., Reuken, P. A., Schattenberg, J. M., Naumann, U., et al. (2024) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2382-7720 · Cited by 12
Giannini, E. G., Pieri, G., Labanca, S., Torres, M. C. P., Gasbarrini, A., Biasini, E., Campani, C., Cazzagon, N., Foschi, F. G., Mega, A., et al. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2022.03.002 · Cited by 12
Self-citationThe Inconvenient Truth of Primary Biliary Cholangitis/Autoimmune Hepatitis Overlap Syndrome
Hussain, N., & Trivedi, P. J. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.06.007 · Cited by 16
Matsumoto, K., Hirohara, J., Takeuchi, A., Miura, R., Asaoka, Y., Nakano, T., & Tanaka, A. (2023) · Hepatology Research · doi:10.1111/hepr.13931 · Cited by 12
Namisaki, T., Fujinaga, Y., Moriya, K., & Yoshiji, H. (2020) · Hepatology Research · doi:10.1111/hepr.13593 · Cited by 11
Letter: histology is relevant for risk stratification in primary biliary cholangitis
Carbone, M., D’Amato, D., Hirschfield, G. M., Jones, D. E., & Mells, G. F. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15583 · Cited by 11
Self-citationThe treatment of primary biliary cholangitis: from shadow to light
Dražilová, S., Koky, T., Macej, M., Janíčko, M., Simkova, D., & Jarčuška, P. (2024) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848241265782 · Cited by 12
Li, J., Lü, M., Zhou, Y., Bowlus, C. L., Lindor, K. D., Rodriguez‐Watson, C., Romanelli, R. J., Haller, I. V., Anderson, H., VanWormer, J. J., et al. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07219-4 · Cited by 10
Chang, J.-I., Kim, J. H., Sinn, D. H., Cho, J., Kim, K. M., Oh, J. H., Park, Y., Sohn, W., Goh, M. J., Kang, W., et al. (2023) · Gut and Liver · doi:10.5009/gnl220420 · Cited by 10
The latest research trends in primary biliary cholangitis: a bibliometric analysis
Zhao, Y., Yin, Z., Du, H., Huang, K., Zhang, F., & Chen, H. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00825-0 · Cited by 9
Risk Stratification in Primary Biliary Cholangitis
Martini, F., Balducci, D., Mancinelli, M., Buzzanca, V., Fracchia, E., Tarantino, G., Benedetti, A., Marzioni, M., & Maroni, L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175713 · Cited by 11
Self-citationPrognostic models and autoimmune liver diseases
D’Amato, D., & Carbone, M. (2023) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2023.101878 · Cited by 10
Self-citationPrecision medicine in primary biliary cholangitis
Ronca, V., Gerussi, A., Cristoferi, L., Carbone, M., & Invernizzi, P. (2019) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12787 · Cited by 9
Self-citationChang, M., Chen, W., Chan, T., Lin, C.-Y., Chang, M.-Y., Chen, S.-C., & Chien, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.869018 · Cited by 10
Kimura, N., Takahashi, K., Setsu, T., Horibata, Y., Kaneko, Y., Miyazaki, H., Ogawa, K., Kawata, Y., Sakai, N., Watanabe, Y., et al. (2023) · Hepatology Research · doi:10.1111/hepr.13966 · Cited by 8
Cançado, G. G. L., Fucuta, P. D. S., Gomes, N. M. D. F., Couto, C. A., Cançado, E. L. R., Terrabuio, D. R. B., Villela‐Nogueira, C. A., Braga, M. H., Nardelli, M. J., Faria, L. C., et al. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102453 · Cited by 8
The Treatment of Primary Biliary Cholangitis: Time for Personalized Medicine
Men, X., Liu, Y., Zhao, H., Xie, B., Guo, C., Leung, P. S. C., Timilsina, S., Gershwin, M. E., Shang, Y., & Han, Y. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09074-x · Cited by 12
Bossen, L., Lau, T. S., Nielsen, M. B., Nielsen, M. C., Andersen, A. H., Ott, P., Becker, S., Glerup, H., Svenningsen, L., Eivindson, M., et al. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000068 · Cited by 8
Patient ownership of primary biliary cholangitis long-term management
Leighton, J., Thain, C., Mitchell-Thain, R., Dyson, J. K., & Jones, D. E. J. (2020) · Frontline Gastroenterology · doi:10.1136/flgastro-2019-101324 · Cited by 8
Self-citationKnockout of secretin ameliorates biliary and liver phenotypes during alcohol-induced hepatotoxicity
Kyritsi, K., Wu, N., Zhou, T., Carpino, G., Baiocchi, L., Kennedy, L. L., Chen, L., Ceci, L., Meyer, A., Barupala, N. P., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-022-00945-w · Cited by 8
Self-citationInvestigational drugs in early phase development for primary biliary cholangitis
Gochanour, E. M., & Kowdley, K. V. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1857364 · Cited by 8
Terracciani, F., Vincentis, A. D., D’Amato, D., Cristoferi, L., Gerussi, A., Invernizzi, P., Scaravaglio, M., Vanni, E., Campion, D., Morgando, A., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101448 · Cited by 7
Self-citationPrimary biliary cholangitis: current insights and novel therapies
Granito, A., Παππάς, Γ., Napoli, L., Stefanini, B., Tirotta, D., & Muratori, P. (2026) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2026.2672493 · Cited by 8
Huang, L.-X., Wang, Z., Jin, R., Chen, H., & Feng, B. (2022) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2022.2153672 · Cited by 8
Xie, X., Huang, R., Zhang, W., & Zhang, R. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136328 · Cited by 7
Primary biliary cholangitis (PBC): evolving approaches and expert perspectives
Invernizzi, P., Aghemo, A., Calvaruso, V., Lleò, A., Marzioni, M., Piscaglia, F., Rigamonti, C., Gentilucci, U. V., Brillanti, S., Carbone, M., et al. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2601220 · Cited by 6
Self-citationPredictive Model of Ursodeoxycholic Acid Treatment Response in Primary Biliary Cholangitis
Shu, Y.-Y., Song, Y., Bai, T., Pan, X., Shang, H., Yang, L., Ye, J., & Du, F. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00127 · Cited by 6
Gazda, J., Dražilová, S., Janíčko, M., Grgurević, I., Kanižaj, T. F., Koller, T., Bodorovska, B., Božin, T., Mijić, M., Rob, Z., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060495 · Cited by 6
Gazda, J., Janicko, M., Drazilova, S., Grgurevic, I., Kanizaj, T. F., Koller, T., Bodorovska, B., Mijic, M., Mikolasevic, I., Stromar, I. K., et al. (2021) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2021/9928065 · Cited by 6
Yehezkel, E., Israel, I., Houri, I., Leshno, M., Shibolet, O., & Zigmond, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194551 · Cited by 6
Review Article: Targeting Peroxisome Proliferator‐Activated Receptors in Primary Biliary Cholangitis
Schattenberg, J. M., Bañales, J. M., Hirschfield, G. M., Trivedi, P., Cable, E. E., McWherter, C. A., Billin, A. N., Crittenden, D. B., & Budas, G. R. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70598 · Cited by 5
Self-citationPrognostic Scoring Systems in Primary Biliary Cholangitis: An Update.
Scaravaglio, M., & Carbone, M. (2022) · Clinical Liver Disease · doi:10.1016/j.cld.2022.06.005 · Cited by 4
Self-citationPrimary biliary cholangitis: perception and expectation of illness
Floreani, A., Scaffidi, M., Coco, B. A., Giannini, E. G., Labanca, S., Bonaiuto, E., Martin, S. D., Invernizzi, P., Carbone, M., Alvaro, D., et al. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2022.02.006 · Cited by 5
Self-citationGerussi, A., & Carbone, M. (2020) · doi:10.1002/9781119532637.ch7 · Cited by 5
Self-citationReviewing novel findings and advances in diagnoses and treatment of primary biliary cholangitis
Floreani, A., Gabbia, D., & Martin, S. D. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2537192 · Cited by 4
Self-citationWetten, A., Jones, D. E. J., & Dyson, J. K. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1940135 · Cited by 4
Self-citationScaravaglio, M., Carbone, M., & Invernizzi, P. (2023) · Minerva Gastroenterology · doi:10.23736/s2724-5985.22.03279-x · Cited by 4
Self-citationPrognostic scores in primary biliary cholangitis
Tababi, R., Mrabet, S., Akkari, I., Harbi, R., & Jazia, E. B. (2024) · Future Science OA · doi:10.2144/fsoa-2023-0203 · Cited by 4
Metadata
- Authors
- Carbone, M., Nardi, A., Flack, S., Carpino, G., Varvaropoulou, N., Gavrila, C., Spicer, A., Badrock, J., Bernuzzi, F., Cardinale, V., Ainsworth, H. F., Heneghan, M. A., Thorburn, D., Bathgate, A., Jones, R., Neuberger, J. M., Battezzati, P. M., Zuin, M., Taylor-Robinson, S., Donato, M. F., Kirby, J., Mitchell-Thain, R., Floreani, A., Sampaziotis, F., Muratori, L., Alvaro, D., Marzioni, M., Miele, L., Marra, F., Giannini, E., Gaudio, E., Ronca, V., Bonato, G., Cristoferi, L., Malinverno, F., Gerussi, A., Stocken, D. D., Cordell, H. J., Hirschfield, G. M., Alexander, G. J., Sandford, R. N., Jones, D. E., Invernizzi, P., Mells, G. F., Thomas, C., Rahman, M., Yapp, T., Lye Ch'ng, C., Harrison, M., Sturgess, R., Galaska, R., Healey, C., Whiteman, J., Czaijkowski, M., Gray, C., Gunasekera, A., Gyawli, P., Premchand, P., Mann, S., Elliott, K., Kapur, K., Watson, A., Foster, G., Trembling, P., Subhani, J., Harvey, R., McCorry, R., Adgey, C., Hobson, L., Mulvaney-Jones, C., Evans, R., Mathialahan, T., Ramanaden, D., Gasem, J., Van Duyvenvoorde, G., Shorrock, C., Seward, K., Southern, P., Tibble, J., Penn, R., Gorard, D., Maiden, J., Damant, R., Palegwala, A., Jones, S., Alexander, G., Mells, G., Sandford, R., Whiteman, J., Dolwani, S., Prince, M., Silvestre, V., Foxton, M., Dungca, E., Mitchison, H., Wheatley, N., Gooding, I., Doyle, H., Karmo, M., Kent, M., Saksena, S., Braim, D., Patel, M., Lord, S., Ede, R., Paton, A., Austin, A., Lancaster, N., Sayer, J., Gibbins, A., Hogben, K., Hovell, C., Fisher, N., Carter, M., Koss, K., Musselwhite, J., Muscariu, F., Piotreowicz, A., McKay, A., Grimley, C., Neal, D., Ting Tan, L., Lim, G., Brighton, J., Foale, C., Ala, A., Saeed, A., Flahive, K., Wood, G., Townshend, P., Ford, C., Brown, J., Kordula, J., Bowles, J., Wilkinson, M., Palmer, C., Ramage, J., Gordon, H., Featherstone, J., Ridpath, J., Ngatchu, T., Levi, S., Shaukat, S., Sadeghian, J., Shidrawi, R., Williams, B., Abouda, G., Jones, S., Duggan, C., Hynes, A., Narain, M., Rees, I., Salam, I., Crossey, M., Taylor-Robinson, S., Brown, A., MacNicol, C., Williams, S., Wilhelmsen, E., Banim, P., Raymode, P., Chilton, A., Das, D., Lee, H.-J., Curtis, H., Heneghan, M., Gess, M., Durant, E., Drake, I., Bishop, R., Davies, M., Jones, R., Aldersley, M., Ncube, N., McNair, A., Srirajaskanthan, R., Sen, S., Casey, R., Bird, G., Mendall, M., Cowley, C., Barnardo, A., Kitchen, P., Yoong, K., Amore, K., Sirdefield, D., Orpe, J., Mathew, R., MacFaul, G., Wrigth, A., Shah, A., Evans, C., Keggans, J., Bird, B., Baxter, G., Saha, S., Pollock, K., Hughes, M., Bramley, P., Grieve, E., Young, K., Fraser, A., Mukhopadhya, A., Ocker, K., Mills, P., Hines, F., Shallcross, C., Wilkins, J., Grellier, L., Campbell, S., Martin, K., Bathgate, A., Innes, C., Shepherd, A., Rushbrook, S., Valliani, T., Przemioslo, R., Fairlamb, H., Macdonald, C., Eastick, A., Metcalf, J., Tanqueray, E., Shmueli, U., Holbrook, B., Davis, A., Browning, J., Naqvi, A., Walker, K., Lee, T., Verheyden, J., Slininger, S., Ryder, S. D., Chapman, R., Collier, J., O'Donnell, D., Stafford, L., Williamson, K., Kent, L., Klass, H., Ninkovic, M., March, L., Cramp, M., Simpson, D., Dickson, C., Sharer, N., Hayes, M., Goggin, P., Quinne, M., Pearson, S., Hoeroldt, B., Jones, L., Wright, A., Booth, J., Loftus, A., Lipscomb, G., Dewhurst, H., Gunter, E., Williams, E., Fouracres, A., Farrington, L., Graves, L., Hussaini, H., Stableforth, B., Marriott, S., Ayres, R., Leoni, M., Burroughs, A., Marshall, E., Thorburn, D., Tyrer, D., Martin, K., Lombard, M., Patanwala, I., Dali-Kemmery, L., Lambourne, V., Maltby, J., Vyas, S., Colley, J., Shinder, B., Singhal, S., Jones, J., Mills, M., Gleeson, D., Carnahan, M., Butterworth, J., Boulton, K., Taylor, N., George, K., Harding, T., Tregonning, J., Douglass, A., Brown, C., Clifford, G., Panter, S., Gocher, D., Shearman, J., Bray, G., Hamilton, M., Butcher, G., Forton, D., Mclindon, J., Curtis, J., Das, D., Shewan, T., Cowan, M., Whatley, G., Nasseri, M., Grover, B., Sivaramakrishnan, N., Ducker, S., Houghton, K., Jones, D., Griffiths, L., Tripoli, S., Pitcher, M., Shpuza, E., White, N., Ghosh, D., Douds, A., Green, M., Brookes, M., Cumlat, L., Wong, V. S., Warner, K., Netherton, K., Mandal, A., Jain, S., Gupta, H., Sanghi, P., Pereira, S., Neuberger, J., Gunson, B., Hirschfield, G., Lim, R. T., Gallagher, S., Clement, D., Brind, A., Watts, G., Mupudzi, M., Wright, M., Gitahi, J., Gordon, F., Gocher, D., Unitt, E., Pateman, H., Batham, S., Delahooke, T., Grant, A., Conder, J., Higham, A., Cox, M., O'Donohoe, L., Currie, L., King, A., Oblak, M., Collins, C., Whalley, S., Quinn, M., Baird, Y., Amey, I., Fraser, J., Li, A., Cotterill, D., Bell, A., Watson, A., Singhal, A., Gee, I., Greer, S., Ang, Y., Ransford, R., Allison, J., Gotto, J., Dyer, S., Sweeting, H., Millson, C., Invernizzi, P., Carbone, M., Cristoferi, L., Bonato, G., Malinverno, F., Bernuzzi, F., Alvaro, D., Labbadia, G., Bragazzi, M. C., Andreone, P., Muratori, L., Azzaroli, F., Floreani, A., Galli, A., Tarocchi, M., Giannini, E., Miele, L., Gasbarrini, A., Grieco, A., Marrone, G., Donato, M. F., Valenti, L., Marra, F., Marzioni, M., Maroni, L., Rigamonti, C., Zuin, M., Battezzati, P. M., & Picciotto, A.
- Affiliations
- University of Rome Tor Vergata (IT)
- University of Cambridge (GB)
- Foro Italico University of Rome (IT)
- Sapienza University of Rome (IT)
- Newcastle University (GB)
- PBC Foundation (GB)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- Ospedale San Paolo (IT)
- University of Milano-Bicocca (IT)
- Edinburgh Royal Infirmary (GB)
- Queen Elizabeth Hospital Birmingham (GB)
- Imperial College London (GB)
- St James's University Hospital (GB)
- University of Milan (IT)
- University of Padua (IT)
- Agostino Gemelli University Polyclinic (IT)
- ORCID
- Nardi, Alessandra
- Carpino, Guido
- Cardinale, Vincenzo
- Kirby, John
- Mitchell-Thain, Robert
- Sampaziotis, Fotios
- Gaudio, Eugenio
- Ronca, Vincenzo
- Gerussi, Alessio
- Stocken, Deborah D
- Cordell, Heather J
- Gray, Catherine
- Kapur, Kapil
- Foster, Graham
- Trembling, Paul
- Tibble, Jeremy
- Dolwani, Sunil
- Fisher, Neil
- Ala, Aftab
- Brown, Jonathan
- Wilkinson, Mark
- Palmer, Caroline
- Ramage, John
- Shidrawi, Ray
- Williams, Bronwen
- Jones, Sarah
- Banim, Paul
- Das, Debasish
- Lee, Hye-Jeong
- Aldersley, Mark
- Ncube, Noma
- Cowley, Caroline
- MacFaul, George
- Fraser, Andrew
- Mills, Peter
- Grellier, Leonie
- Campbell, Stewart
- Rushbrook, Simon
- Valliani, Talal
- Przemioslo, Robert
- Lee, Tom
- Ryder, Stephen D
- Chapman, Roger
- Collier, Jane
- Stafford, Lizzie
- Cramp, Matthew
- Hoeroldt, Barbara
- Jones, Linda
- Dewhurst, Hannah
- Burroughs, Andrew
- Patanwala, Imran
- Gleeson, Dermot
- George, Keith
- Harding, Tim
- Clifford, Gayle
- Forton, Daniel
- Cowan, Matthew
- Ghosh, Deb
- Douds, Andrew
- Brookes, Matthew
- Gupta, Hemant
- Gunson, Bridget
- Wright, Mark
- Gordon, Fiona
- Batham, Sally
- Collins, Carole
- Whalley, Simon
- Singhal, Amit
- Ang, Yeng
- Millson, Charles
- Labbadia, Giancarlo
- Bragazzi, Maria Consiglia
- Azzaroli, Francesco
- Galli, Andrea
- Tarocchi, Mirko
- Gasbarrini, Antonio
- Grieco, Antonio
- Marrone, Giuseppe
- Valenti, Luca
- Maroni, Luca
- Rigamonti, Cristina
- Venue
- The Lancet Gastroenterology & Hepatology
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 3
- Issue
- 9
- Pages
- 626-634
- ISSN
- 2468-1156 (ISSN-L)
- 2468-1253
- PMC
- PMC6962055
- OpenAlex
- W2883784290
- Semantic Scholar
- cd10e32484b0f06ad9d9e15fe1b21304b3b08b07
- Cited by
- 155
- References
- 26
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 20 · 2023: 23 · 2022: 19 · 2021: 23 · 2020: 23 · 2019: 15 · 2018: 4
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Lancet. Gastroenterology & hepatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion, other-oa)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, other-oa)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, other-oa)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- Florence Research (University of Florence) (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion, other-oa)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust (085925)
- NIHR Imperial Biomedical Research Centre
- Intercept Pharmaceuticals
- Birmingham Biomedical Research Centre
- Medical Research Council (MR/L001489/1)
- NIHR Nottingham Biomedical Research Centre
- National Institute for Health and Care Research
- Isaac Newton Trust
- Università degli Studi di Milano-Bicocca
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- primary biliary cirrhosis, ursodeoxycholic acid, alkaline phosphatase, total bilirubin, transaminases, liver biopsy histology, ductular reaction, liver fibrosis, biliary injury, second-line therapy, external validation
- MeSH terms
- Alkaline Phosphatase, Transaminases, Bilirubin, Cholagogues and Choleretics, Decision Support Techniques, Female, Humans, Liver Cirrhosis, Biliary, Male, Middle Aged, Risk Factors, ROC Curve, Ursodeoxycholic Acid, Linear Models, Treatment Outcome, Age of Onset, Area Under Curve, Time-to-Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review